cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA300230 | uterus | .d | 509 to 731 | 1 to 223 | tiling clone, | 223/223 (100 %) | 0 diff (100 %id) | ||
AI940618 | stomach | .b | 1081 to 1626 | 558 to 13 | 546/558 (97 %) | 4 diff (99.3 %id) | |||
AI940625 | stomach | .b | 1225 to 1624 | 426 to 28 | 399/426 (93 %) | 3 diff (99.3 %id) | |||
AI940633 | stomach | .b | 1157 to 1626 | 478 to 7 | 472/478 (98 %) | 3 diff (99.4 %id) | |||
AI940653 | stomach | .b | 1140 to 1624 | 491 to 8 | 484/491 (98 %) | 2 diff (99.6 %id) | |||
AI940660 | stomach | .b | 1081 to 1626 | 558 to 13 | 546/558 (97 %) | 4 diff (99.3 %id) | |||
AK310917 | trachea | .c | 1 to 1843 | 2 to 1844 | Q48* | tiling clone, | 1844/1844 (100 %) | 3 diff (99.9 %id) | |
AK313388 | trachea | .b | 279 to 1850 | 1 to 1572 | exact | 1572/1572 (100 %) | 0 diff (100 %id) | ||
AW362652 | colon | .b | 1735 to 1904 | 170 to 1 | 170/187 (90 %) | 2 diff (99.0 %id) | |||
AW365613 | head_neck | .b | 1334 to 1809 | 475 to 1 | 475/476 (99 %) | 6 diff (98.8 %id) | |||
AW365668 | head_neck | .b | 824 to 1431 | 11 to 628 | 618/643 (96 %) | 12 diff (98.2 %id) | |||
AW366796 | head_neck | .b | 1766 to 1890 | 1 to 124 | 124/131 (94 %) | 3 diff (97.8 %id) | |||
AW369391 | breast_normal | .b | 417 to 778 | 1 to 364 | 364/364 (100 %) | 2 diff (99.5 %id) | |||
AW374300 | colon | .b | 911 to 1317 | 414 to 7 | 408/423 (96 %) | 0 diff (100 %id) | |||
AW374307 | colon | .b | 952 to 1626 | 679 to 7 | 673/681 (98 %) | 0 diff (100 %id) | |||
AW374312 | colon | .b | 978 to 1615 | 634 to 1 | 634/634 (100 %) | 8 diff (98.8 %id) | |||
AW374318 | colon | .b | 977 to 1605 | 625 to 2 | 624/628 (99 %) | 10 diff (98.5 %id) | |||
AW375948 | colon | .b | 426 to 596 | 5 to 174 | 170/174 (97 %) | 7 diff (96.0 %id) | |||
AW376365 | colon | .b | 1597 to 1909 | 454 to 142 | 313/454 (68 %) | 0 diff (100 %id) | |||
AW389752 | stomach | .b | 1762 to 1913 | 152 to 1 | 152/285 (53 %) | 0 diff (100 %id) | |||
AW392656 | stomach | .b | 1219 to 1430 | 233 to 21 | 213/233 (91 %) | 1 diff (99.6 %id) | |||
AW601821 | breast | .b | 1686 to 2211 | 530 to 5 | 526/530 (99 %) | 0 diff (100 %id) | |||
AW751488 | colon | .b | 1767 to 2148 | 406 to 24 | 383/425 (90 %) | 3 diff (99.3 %id) | |||
AW853512 | colon | .b | 1369 to 1847 | 19 to 504 | 484/520 (93 %) | 33 diff (93.7 %id) | |||
AW970628 | .b | 2183 to 2519 | 122 to 458 | AAA | 337/458 (73 %) | 6 diff (98.7 %id) | |||
AW994447 | breast_normal | .b | 1509 to 2152 | 1 to 643 | 643/652 (98 %) | 12 diff (98.2 %id) | |||
BC009742 | Placenta, choriocarcinoma | .b | 62 to 2898 | 1 to 2837 | exact | tiling clone, available from MGC, AAA | 2837/2837 (100 %) | 1 diff (100.0 %id) | |
BC071890 | Pancreas, ductal carcinoma | .b | 1 to 2524 | 1 to 2524 | T274A K323E | tiling clone, available from MGC, AAA | 2524/2524 (100 %) | 3 diff (99.9 %id) | |
BE083633 | breast | .b | 577 to 854 | 499 to 222 | Submitted on the opposite strand | 278/506 (54 %) | 0 diff (100 %id) | ||
BE714141 | head_neck | .b | 1563 to 1752 | 211 to 23 | 189/214 (88 %) | 2 diff (99.1 %id) | |||
BE714142 | head_neck | .b | 1575 to 1752 | 185 to 9 | 177/185 (95 %) | 1 diff (99.5 %id) | |||
BE838489 | prostate_normal | .g-u | 45 to 327 | 292 to 7 | 286/295 (96 %) | 0 diff (100 %id) | |||
BF736328 | bladder_tumor | .b | 1387 to 1761 | 380 to 6 | Submitted on the opposite strand | 375/380 (98 %) | 6 diff (98.5 %id) | ||
BF736819 | bladder_tumor | .b | 876 to 1301 | 436 to 4 | Submitted on the opposite strand | 433/436 (99 %) | 0 diff (100 %id) | ||
BF737107 | bladder_tumor | .b | 2095 to 2379 | 1 to 285 | 285/295 (96 %) | 9 diff (97.0 %id) | |||
BF737124 | bladder_tumor | .b | 2080 to 2305 | 242 to 31 | Submitted on the opposite strand | 212/242 (87 %) | 0 diff (100 %id) | ||
BF737129 | bladder_tumor | .g-u | 267 to 567 | 1 to 297 | 297/297 (100 %) | 6 diff (98.0 %id) | |||
BF739152 | bladder_tumor | .g-u | 55 to 475 | 434 to 14 | Submitted on the opposite strand | 421/437 (96 %) | 0 diff (100 %id) | ||
BF754423 | colon | .b | 1367 to 1611 | 24 to 279 | 256/279 (91 %) | 21 diff (92.5 %id) | |||
BF764625 | colon_est | .b | 2184 to 2385 | 13 to 216 | 204/220 (92 %) | 6 diff (97.3 %id) | |||
BF772249 | epid_tumor | .b | 1804 to 1962 | 1 to 162 | 162/169 (95 %) | 14 diff (91.8 %id) | |||
BF812178 | colon_ins | .b | 1659 to 1913 | 303 to 49 | Submitted on the opposite strand | 255/303 (84 %) | 2 diff (99.4 %id) | ||
BF834553 | head_neck | .b | 1295 to 1402 | 130 to 20 | Submitted on the opposite strand | 111/130 (85 %) | 0 diff (100 %id) | ||
BF835784 | head_neck | .b | 1681 to 2026 | 131 to 479 | 351/479 (73 %) | 6 diff (98.8 %id) | |||
BF836557 | head_neck | .b | 1641 to 1994 | 369 to 10 | Submitted on the opposite strand | 360/371 (97 %) | 4 diff (99.0 %id) | ||
BF882777 | lung_tumor | .b | 1764 to 1893 | 1 to 128 | 128/128 (100 %) | 8 diff (93.8 %id) | |||
BF883594 | lung_tumor | .b | 1169 to 1529 | 362 to 1 | Submitted on the opposite strand | 362/362 (100 %) | 3 diff (99.2 %id) | ||
BF914747 | uterus_tumor | .b | 1704 to 1946 | 1 to 243 | 243/243 (100 %) | 0 diff (100 %id) | |||
BF916953 | uterus_tumor | .g-u | 100 to 377 | 283 to 3 | Submitted on the opposite strand | 281/297 (94 %) | 0 diff (100 %id) | ||
BG009649 | placenta_normal | .g-u | 1 to 550 | 556 to 11 | P75X P96H | tiling clone, | 546/573 (95 %) | 0 diff (100 %id) | |
BG185486 | .b | 1321 to 2085 | 4 to 772 | 769/772 (99 %) | 32 diff (95.9 %id) | ||||
BG945257 | amnion_normal | .b | 1026 to 1406 | 74 to 442 | 369/443 (83 %) | 7 diff (98.5 %id) | |||
BG980211 | colon_normal | .b | 1621 to 2041 | 420 to 2 | 419/420 (99 %) | 0 diff (100 %id) | |||
BG980318 | colon_normal | .i | 1 to 331 | 29 to 359 | exact | tiling clone, | 331/359 (92 %) | 7 diff (98.1 %id) | |
BG986329 | head_neck | .k-u | 1 to 286 | 3 to 295 | V2W S3F L6F W7G S8A ... | tiling clone, | 293/295 (99 %) | 16 diff (94.6 %id) | |
BG987611 | head_neck | .b | 1044 to 1233 | 6 to 188 | 183/188 (97 %) | 6 diff (96.9 %id) | |||
BG987916 | head_neck | .g-u | 214 to 590 | 1 to 377 | 377/380 (99 %) | 28 diff (92.7 %id) | |||
BI017056 | lung_tumor | .b | 1793 to 2387 | 603 to 15 | 589/603 (97 %) | 5 diff (99.2 %id) | |||
BI063135 | uterus_tumor | .b | 1713 to 2187 | 475 to 1 | 475/475 (100 %) | 0 diff (100 %id) | |||
DA039989 | bladder | .b | 280 to 841 | 2 to 563 | capped | 562/565 (99 %) | 1 diff (99.9 %id) | ||
DA042162 | bladder | .b | 281 to 786 | 2 to 508 | capped | 507/507 (100 %) | 2 diff (99.7 %id) | ||
BQ300021 | bladder_tumor | .g-u | 46 to 482 | 436 to 1 | 436/436 (100 %) | 9 diff (98.0 %id) | |||
BQ300165 | bladder_tumor | .h | 486 to 717 | 1 to 231 | tiling clone, | 231/231 (100 %) | 6 diff (97.5 %id) | ||
BQ300359 | bladder_tumor | .b | 2080 to 2340 | 258 to 5 | 254/258 (98 %) | 0 diff (100 %id) | |||
BQ300393 | bladder_tumor | .g-u | 275 to 567 | 291 to 1 | 291/291 (100 %) | 2 diff (99.4 %id) | |||
BQ300461 | bladder_tumor | .b | 2157 to 2353 | 207 to 3 | 205/207 (99 %) | 0 diff (100 %id) | |||
BQ361502 | ovary | .b | 1003 to 1419 | 419 to 3 | 417/435 (95 %) | 6 diff (98.7 %id) | |||
BQ362219 | stomach | .b | 1358 to 1625 | 268 to 2 | 267/268 (99 %) | 9 diff (96.7 %id) | |||
BQ362463 | stomach | .b | 1529 to 1896 | 371 to 4 | 368/371 (99 %) | 3 diff (99.2 %id) | |||
DA374961 | thalamus | .e | 1 to 564 | 2 to 565 | exact | tiling clone, capped | 564/564 (100 %) | 0 diff (100 %id) | |
BX107960 | liver and spleen | .b | 1379 to 2105 | 1 to 727 | 727/727 (100 %) | 1 diff (99.9 %id) | |||
BX283144 | astrocytoma grade IV, cell line, brain | .b | 309 to 809 | 1 to 501 | 501/501 (100 %) | 1 diff (99.9 %id) | |||
BX647307 | esophagus tumor | .a | 59 to 2329 | 1 to 2268 | tiling clone, available from DKFZ, AAA | 2268/2268 (100 %) | 8 diff (99.7 %id) | ||
CD620759 | .b | 1592 to 1997 | 411 to 7 | 405/416 (97 %) | 0 diff (100 %id) | ||||
CD620760 | .b | 1587 to 1985 | 1 to 399 | 399/417 (95 %) | 5 diff (98.9 %id) | ||||
CN292335 | embryonic stem cells, DMSO-treated H9 cellline | .b | 246 to 966 | 1 to 721 | 721/721 (100 %) | 2 diff (99.8 %id) | |||
CN292336 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .g-u | 40 to 722 | 1 to 683 | tiling clone, | 683/684 (99 %) | 6 diff (99.2 %id) | ||
CN292337 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .b | 97 to 578 | 1 to 483 | 483/483 (100 %) | 2 diff (99.6 %id) | |||
CN292338 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .b | 1714 to 2318 | 1 to 605 | 605/605 (100 %) | 4 diff (99.4 %id) | |||
CN292339 | embryonic stem cells, DMSO-treated H9 cellline | .b | 1498 to 1912 | 9 to 423 | 415/423 (98 %) | 6 diff (98.6 %id) | |||
CN414484 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .b | 2384 to 2525 | 1 to 142 | AAA | 142/142 (100 %) | 0 diff (100 %id) | ||
BP223526 | colon mucosa | .b | 280 to 856 | 1 to 574 | 574/575 (99 %) | 6 diff (99.0 %id) | |||
BP223531 | colon mucosa | .b | 280 to 982 | 1 to 706 | 706/706 (100 %) | 13 diff (98.2 %id) | |||
DA435273 | tongue, tumor tissue | .b | 282 to 869 | 2 to 589 | capped | 588/588 (100 %) | 0 diff (100 %id) | ||
DA438834 | tongue, tumor tissue | .b | 280 to 862 | 2 to 584 | capped | 583/583 (100 %) | 2 diff (99.7 %id) | ||
DA452225 | tongue, tumor tissue | .d | 1 to 594 | 2 to 595 | tiling clone, capped | 594/594 (100 %) | 0 diff (100 %id) | ||
CU443990 | epidermis | .b | 1644 to 1955 | 46 to 358 | 313/368 (85 %) | 12 diff (96.8 %id) | |||
CU446189 | epidermis | .b | 1344 to 1844 | 31 to 531 | 501/612 (81 %) | 8 diff (98.7 %id) | |||
CU447609 | epidermis | .b | 1320 to 2111 | 1 to 793 | 793/793 (100 %) | 10 diff (98.8 %id) | |||
CU447705 | epidermis | .b | 1794 to 2119 | 344 to 19 | Submitted on the opposite strand | 326/354 (92 %) | 0 diff (100 %id) | ||
CU447734 | epidermis | .g-u | 246 to 490 | 270 to 25 | Submitted on the opposite strand | 246/281 (87 %) | 0 diff (100 %id) | ||
CU447896 | epidermis | .b | 1133 to 1260 | 194 to 67 | Submitted on the opposite strand | 128/211 (60 %) | 0 diff (100 %id) | ||
CU448075 | epidermis | .b | 1335 to 2001 | 17 to 683 | 667/683 (97 %) | 9 diff (98.7 %id) | |||
CU448290 | epidermis | .b | 1259 to 1921 | 679 to 17 | Submitted on the opposite strand | 663/679 (97 %) | 1 diff (99.9 %id) | ||
CU448608 | epidermis | .b | 1673 to 2396 | 736 to 13 | Submitted on the opposite strand | 724/736 (98 %) | 0 diff (100 %id) | ||
CU449075 | epidermis | .b | 1794 to 2643 | 11 to 860 | 850/860 (98 %) | 7 diff (99.2 %id) | |||
CU450051 | epidermis | .b | 1794 to 1931 | 11 to 148 | 138/156 (88 %) | 10 diff (93.6 %id) | |||
CU450449 | epidermis | .b | 1286 to 1949 | 673 to 10 | Submitted on the opposite strand | 664/673 (98 %) | 2 diff (99.8 %id) | ||
CU450617 | epidermis | .b | 1782 to 1964 | 1 to 184 | 184/215 (85 %) | 14 diff (93.5 %id) | |||
CU451576 | epidermis | .b | 1210 to 1820 | 14 to 624 | 611/624 (97 %) | 6 diff (99.1 %id) | |||
CU452480 | epidermis | .b | 1794 to 2179 | 410 to 25 | Submitted on the opposite strand | 386/420 (91 %) | 0 diff (100 %id) | ||
CU454551 | epidermis | .b | 845 to 927 | 7 to 89 | 83/103 (80 %) | 6 diff (94.2 %id) | |||
CU456046 | epidermis | .b | 1794 to 2114 | 11 to 331 | 321/331 (96 %) | 9 diff (97.3 %id) | |||
CU456202 | epidermis | .b | 1290 to 1949 | 670 to 10 | Submitted on the opposite strand | 661/670 (98 %) | 2 diff (99.8 %id) | ||
CU456279 | epidermis | .b | 1641 to 2396 | 768 to 13 | Submitted on the opposite strand | 756/768 (98 %) | 0 diff (100 %id) | ||
CU457303 | epidermis | .b | 1794 to 1943 | 168 to 18 | Submitted on the opposite strand | 151/178 (84 %) | 0 diff (100 %id) | ||
CV361554 | bladder_tumor | .b | 2196 to 2372 | 131 to 302 | 246/302 (81 %) | 25 diff (91.8 %id) | |||
BX479962 | .b | 288 to 979 | 1 to 692 | 692/692 (100 %) | 1 diff (99.9 %id) | ||||
EC442433 | Prostate | .b | 850 to 938 | 7 to 95 | 89/95 (93 %) | 6 diff (93.7 %id) | |||
EC471548 | Prostate | .b | 1915 to 2018 | 105 to 1 | 105/105 (100 %) | 1 diff (99.1 %id) | |||
EC562505 | Prostate | .b | 1584 to 1688 | 105 to 1 | 105/105 (100 %) | 0 diff (100 %id) | |||
EC564719 | Prostate | .b | 1587 to 1686 | 101 to 3 | 99/105 (94 %) | 0 diff (100 %id) | |||
BP231438 | muscle | .h | 1 to 581 | 1 to 582 | I40T Q59* | tiling clone, | 582/582 (100 %) | 3 diff (99.5 %id) | |
BP240940 | Liver | .b | 279 to 850 | 1 to 572 | 572/572 (100 %) | 2 diff (99.7 %id) | |||
BP240981 | Liver | .b | 279 to 845 | 1 to 567 | 567/567 (100 %) | 2 diff (99.7 %id) | |||
BP242751 | Liver | .b | 410 to 941 | 1 to 532 | 532/572 (93 %) | 28 diff (95.2 %id) | |||
BJ993031 | hepatoblastoma | .b | 352 to 951 | 1 to 600 | 600/600 (100 %) | 4 diff (99.4 %id) | |||
BP252066 | Kidney | .b | 956 to 1535 | 1 to 580 | 580/580 (100 %) | 6 diff (99.0 %id) | |||
T97710 | liver and spleen | .b | 2237 to 2518 | 289 to 7 | 283/289 (97 %) | 0 diff (100 %id) | |||
T97813 | liver and spleen | .b | 1380 to 1659 | 1 to 282 | 282/293 (96 %) | 5 diff (98.3 %id) | |||
W60466 | Pancreas, pancreatic islet | .b | 2112 to 2519 | 439 to 26 | AAA | 414/416 (99 %) | 9 diff (97.9 %id) | ||
AA159477 | Pancreas | .b | 2017 to 2521 | 505 to 1 | 505/506 (99 %) | 13 diff (97.5 %id) | |||
AA160436 | Pancreas | .b | 1117 to 1512 | 1 to 387 | 387/387 (100 %) | 10 diff (97.5 %id) | |||
AA252902 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .b | 2187 to 2519 | 334 to 1 | 334/334 (100 %) | 2 diff (99.5 %id) | |||
AA253308 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .b | 1392 to 1902 | 1 to 509 | 509/509 (100 %) | 2 diff (99.7 %id) | |||
AA502830 | ovary | .b | 2177 to 2468 | 1 to 292 | 292/292 (100 %) | 5 diff (98.3 %id) | |||
AA552111 | colon, tumor | .b | 2236 to 2521 | 286 to 1 | 286/286 (100 %) | 0 diff (100 %id) | |||
AA573938 | colon, tumor | .b | 2064 to 2519 | 475 to 20 | AAA | 456/456 (100 %) | 18 diff (96.1 %id) | ||
AA588706 | colon, colon tumor | .b | 2194 to 2519 | 355 to 30 | AAA | 326/326 (100 %) | 0 diff (100 %id) | ||
AA636061 | invasive tumor (cell line), Prostate | .g-u | 267 to 713 | 445 to 1 | 445/445 (100 %) | 3 diff (99.4 %id) | |||
AA715308 | normal prostate, Prostate | .b | 2310 to 2519 | 211 to 1 | 211/214 (98 %) | 3 diff (98.6 %id) | |||
AA934750 | Kidney | .b | 2132 to 2522 | 392 to 1 | 392/392 (100 %) | 2 diff (99.5 %id) | |||
AI186201 | placenta | .b | 2122 to 2519 | 409 to 13 | AAA | 397/397 (100 %) | 1 diff (99.8 %id) | ||
AI262916 | Kidney | .b | 2081 to 2520 | 439 to 4 | 436/439 (99 %) | 0 diff (100 %id) | |||
AI368181 | adenocarcinoma, colon | .b | 2230 to 2524 | 306 to 12 | AAA | 295/295 (100 %) | 3 diff (99.0 %id) | ||
AI318103 | adenocarcinoma, colon | .b | 2134 to 2524 | 407 to 17 | AAA | 391/391 (100 %) | 19 diff (95.2 %id) | ||
AI379539 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .b | 2114 to 2522 | 411 to 3 | 409/411 (99 %) | 0 diff (100 %id) | |||
AI817651 | colon, colon tumor, RER+ | .b | 894 to 1436 | 541 to 1 | 541/541 (100 %) | 9 diff (98.4 %id) | |||
AI394281 | B-cell, chronic lymphotic leukemia | .b | 387 to 780 | 394 to 1 | 394/397 (99 %) | 7 diff (98.3 %id) | |||
AI472809 | pooled | .b | 2212 to 2520 | 311 to 3 | 309/311 (99 %) | 0 diff (100 %id) | |||
AI625947 | colon | .b | 2230 to 2519 | 290 to 1 | 290/290 (100 %) | 0 diff (100 %id) | |||
AI457146 | colon, moderately-differentiated adenocarcinoma | .b | 2120 to 2522 | 422 to 20 | AAA | 403/403 (100 %) | 4 diff (99.1 %id) | ||
AI866782 | brain, tumor, 5 pooled (see description) | .b | 2096 to 2519 | 424 to 1 | 424/424 (100 %) | 1 diff (99.8 %id) | |||
AI682601 | adenocarcinoma, Pancreas | .b | 2367 to 2520 | 155 to 2 | 154/155 (99 %) | 0 diff (100 %id) | |||
AI674909 | adenocarcinoma, Pancreas | .g-u | 266 to 715 | 453 to 4 | 450/453 (99 %) | 0 diff (100 %id) | |||
AI700409 | colon | .j-u | 1 to 287 | 296 to 10 | exact | tiling clone, | 287/296 (96 %) | 0 diff (100 %id) | |
AI824247 | lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) | .b | 2390 to 2519 | 130 to 1 | 130/130 (100 %) | 2 diff (98.5 %id) | |||
AI888802 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .b | 2106 to 2531 | 432 to 7 | 426/432 (98 %) | 0 diff (100 %id) | |||
AI923587 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .g-u | 261 to 714 | 454 to 1 | 454/454 (100 %) | 1 diff (99.8 %id) | |||
AI932621 | adenocarcinoma, Pancreas | .b | 2142 to 2522 | 409 to 29 | AAA | 381/381 (100 %) | 0 diff (100 %id) | ||
AI961488 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .g-u | 255 to 717 | 465 to 2 | 464/465 (99 %) | 0 diff (100 %id) | |||
AW074322 | 2 pooled high-grade transitional celltumors, genitourinary tract | .b | 2357 to 2496 | 155 to 16 | AAA | 140/140 (100 %) | 6 diff (95.8 %id) | ||
AW081928 | esophagus, squamous cell carcinoma | .g-u | 256 to 714 | 459 to 1 | 459/459 (100 %) | 0 diff (100 %id) | |||
AW079392 | colon, moderately differentiated adenocarcinoma | .b | 2187 to 2520 | 334 to 1 | 334/334 (100 %) | 0 diff (100 %id) | |||
AW089967 | ovary, tumor, 5 pooled (see description) | .b | 2093 to 2519 | 453 to 27 | AAA | 427/427 (100 %) | 3 diff (99.3 %id) | ||
AW188566 | colon, moderately differentiated adenocarcinoma | .b | 2180 to 2521 | 371 to 30 | AAA | 342/342 (100 %) | 20 diff (94.2 %id) | ||
AW188567 | colon, moderately differentiated adenocarcinoma | .b | 2167 to 2521 | 389 to 34 | AAA | 356/356 (100 %) | 20 diff (94.4 %id) | ||
AW170508 | cervix, tumor | .g-u | 186 to 715 | 536 to 7 | 530/536 (98 %) | 0 diff (100 %id) | |||
AW291547 | .b | 2370 to 2519 | 167 to 18 | AAA | 150/150 (100 %) | 0 diff (100 %id) | |||
AW572265 | cervix | .g-u | 265 to 720 | 456 to 1 | 456/456 (100 %) | 0 diff (100 %id) | |||
BE292792 | adenocarcinoma cell line, colon | .b | 1673 to 2300 | 1 to 628 | 628/628 (100 %) | 2 diff (99.7 %id) | |||
AW778729 | colon, moderately-differentiated adenocarcinoma | .b | 2729 to 2898 | 170 to 1 | 170/172 (98 %) | 1 diff (99.5 %id) | |||
BE042388 | colon, moderately-differentiated adenocarcinoma | .b | 2203 to 2522 | 323 to 1 | 323/331 (97 %) | 4 diff (98.8 %id) | |||
BF435220 | pooled | .g-u | 238 to 723 | 486 to 1 | tiling clone, | 486/486 (100 %) | 1 diff (99.8 %id) | ||
BE531047 | adenocarcinoma, Pancreas | .b | 1695 to 2250 | 1 to 556 | 556/556 (100 %) | 3 diff (99.5 %id) | |||
BE616124 | adenocarcinoma, Pancreas | .b | 1694 to 2519 | 1 to 821 | AAA | 821/821 (100 %) | 18 diff (97.9 %id) | ||
BE616155 | adenocarcinoma, Pancreas | .b | 1785 to 2532 | 1 to 736 | 736/943 (78 %) | 17 diff (98.2 %id) | |||
BE514578 | adenocarcinoma cell line, ovary | .b | 2778 to 3394 | 1 to 617 | tiling clone, | 617/617 (100 %) | 1 diff (99.9 %id) | ||
BE736954 | adenocarcinoma, Pancreas | .b | 1381 to 2131 | 1 to 750 | 750/1087 (68 %) | 13 diff (98.9 %id) | |||
BE744973 | adenocarcinoma cell line, ovary | .b | 1561 to 2312 | 1 to 740 | 740/897 (82 %) | 19 diff (97.9 %id) | |||
BE868161 | adenocarcinoma, colon | .b | 97 to 812 | 1 to 711 | 711/957 (74 %) | 21 diff (97.9 %id) | |||
BE871206 | adenocarcinoma, colon | .b | 2290 to 2519 | 1 to 229 | 229/229 (100 %) | 1 diff (99.6 %id) | |||
BE899333 | adenocarcinoma cell line, ovary | .b | 2346 to 2922 | 76 to 653 | 578/654 (88 %) | 32 diff (95.2 %id) | |||
BF688519 | eye, normal pigmented retinal epithelium | .b | 995 to 1765 | 1 to 766 | 766/882 (86 %) | 18 diff (98.0 %id) | |||
BF689168 | eye, normal pigmented retinal epithelium | .b | 1855 to 2465 | 631 to 1 | 631/1142 (55 %) | 30 diff (97.4 %id) | |||
BG222333 | moderate to poorly differentiated invasivecarcinoma, tongue | .b | 2280 to 2519 | 275 to 36 | AAA | 240/240 (100 %) | 1 diff (99.6 %id) | ||
BG222571 | normal squamous epithelium, tongue | .b | 2280 to 2519 | 293 to 54 | AAA | 240/240 (100 %) | 4 diff (98.4 %id) | ||
BG259849 | bladder, transitional cell papilloma, cell line | .b | 1448 to 2197 | 1 to 745 | 745/1058 (70 %) | 18 diff (98.3 %id) | |||
BG260795 | bladder, transitional cell papilloma, cell line | .b | 631 to 1367 | 1 to 736 | 736/866 (84 %) | 14 diff (98.4 %id) | |||
BG285844 | bladder, transitional cell papilloma, cell line | .b | 1558 to 2349 | 1 to 786 | 786/787 (99 %) | 22 diff (97.3 %id) | |||
BG290347 | bladder, transitional cell papilloma, cell line | .b | 1821 to 2527 | 1 to 711 | 711/719 (98 %) | 15 diff (98.0 %id) | |||
BG403036 | bladder, transitional cell papilloma, cell line | .b | 1372 to 2179 | 1 to 812 | 812/815 (99 %) | 19 diff (97.7 %id) | |||
BG248534 | adenocarcinoma cell line, colon | .b | 314 to 1057 | 1 to 742 | 742/862 (86 %) | 25 diff (97.1 %id) | |||
BG470361 | adenocarcinoma cell line, colon | .b | 1406 to 1992 | 1 to 587 | 587/587 (100 %) | 2 diff (99.7 %id) | |||
BG540063 | lung | .b | 282 to 1065 | 1 to 782 | 782/782 (100 %) | 16 diff (98.0 %id) | |||
BG675522 | skin, squamous cell carcinoma | .a | 1 to 686 | 1 to 684 | tiling clone, | 684/684 (100 %) | 9 diff (98.7 %id) | ||
BG679912 | skin, squamous cell carcinoma | .b | 1551 to 2411 | 1 to 856 | 856/857 (99 %) | 7 diff (99.2 %id) | |||
BG696087 | skin | .b | 1667 to 2520 | 1 to 850 | AAA | 850/861 (98 %) | 11 diff (98.8 %id) | ||
BG696264 | skin | .b | 1343 to 2161 | 1 to 819 | 819/819 (100 %) | 2 diff (99.8 %id) | |||
BG749741 | eye, normal pigmented retinal epithelium | .b | 943 to 1763 | 1 to 822 | 822/822 (100 %) | 8 diff (99.1 %id) | |||
BG823836 | adenocarcinoma cell line, colon | .b | 493 to 1287 | 1 to 810 | 810/920 (88 %) | 42 diff (95.5 %id) | |||
BG750922 | eye, normal pigmented retinal epithelium | .b | 291 to 951 | 1 to 677 | 631/677 (93 %) | 25 diff (96.4 %id) | |||
BG751236 | eye, normal pigmented retinal epithelium | .b | 1221 to 2104 | 1 to 886 | 886/963 (92 %) | 19 diff (98.1 %id) | |||
BG751534 | eye, normal pigmented retinal epithelium | .b | 299 to 1110 | 1 to 817 | 817/817 (100 %) | 8 diff (99.1 %id) | |||
BG751978 | eye, normal pigmented retinal epithelium | .b | 322 to 831 | 2 to 513 | 512/873 (58 %) | 10 diff (98.9 %id) | |||
BI092904 | cervix | .b | 1349 to 2271 | 1 to 922 | 922/922 (100 %) | 23 diff (97.6 %id) | |||
BI085095 | astrocytoma grade IV, cell line, brain | .b | 637 to 1516 | 1 to 879 | 872/881 (98 %) | 25 diff (97.2 %id) | |||
BI085736 | astrocytoma grade IV, cell line, brain | .b | 1925 to 2447 | 545 to 1 | 545/850 (64 %) | 27 diff (96.9 %id) | |||
BI759430 | pooled colon, kidney, stomach | .b | 292 to 1020 | 1 to 730 | 730/730 (100 %) | 1 diff (99.9 %id) | |||
BI764728 | pooled colon, kidney, stomach | .b | 314 to 1045 | 1 to 731 | 731/731 (100 %) | 3 diff (99.6 %id) | |||
BM050935 | eye, normal pigmented retinal epithelium | .b | 928 to 1686 | 1 to 763 | 763/849 (89 %) | 9 diff (99.0 %id) | |||
BM016977 | astrocytoma grade IV, cell line, brain | .b | 1136 to 1845 | 1 to 716 | 716/780 (91 %) | 18 diff (97.7 %id) | |||
BM908787 | astrocytoma grade IV, cell line, brain | .b | 1465 to 2343 | 10 to 899 | 890/1158 (76 %) | 42 diff (96.4 %id) | |||
BM549092 | astrocytoma grade IV, cell line, brain | .g-u | 170 to 718 | 1 to 549 | 549/549 (100 %) | 0 diff (100 %id) | |||
BM552193 | astrocytoma grade IV, cell line, brain | .b | 310 to 1215 | 1 to 910 | 910/1044 (87 %) | 22 diff (97.9 %id) | |||
BM562719 | astrocytoma grade IV, cell line, brain | .b | 310 to 1275 | 1 to 975 | 975/1030 (94 %) | 28 diff (97.3 %id) | |||
BM128289 | Islets of Langerhans, Pancreas | .b | 309 to 663 | 1 to 355 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 355/433 (81 %) | 5 diff (98.9 %id) | |
BM989899 | lung, Lung Focal Fibrosis | .g-u | 148 to 625 | 9 to 486 | Submitted on the opposite strand | 478/486 (98 %) | 6 diff (98.8 %id) | ||
CB215986 | normal endometrium, late proliferativephase, cycle day 13, uterus | .b | 2316 to 2525 | 1 to 210 | AAA | 210/210 (100 %) | 0 diff (100 %id) | ||
BU191490 | ductal carcinoma, cell line, Pancreas | .b | 3 to 600 | 1 to 600 | 600/1111 (54 %) | 25 diff (97.8 %id) | |||
BQ685301 | ductal carcinoma, cell line, Pancreas | .b | 304 to 1167 | 1 to 870 | 870/871 (99 %) | 16 diff (98.2 %id) | |||
BQ888175 | ductal carcinoma, cell line, Pancreas | .b | 1384 to 2069 | 1 to 695 | 695/984 (70 %) | 23 diff (97.7 %id) | |||
BU859859 | adenocarcinoma, cell line, breast | .b | 1489 to 2373 | 1 to 888 | 888/888 (100 %) | 9 diff (99.0 %id) | |||
CF147361 | CNCAP(3)T-225 cell line, Prostate | .b | 864 to 1272 | 9 to 417 | 409/417 (98 %) | 2 diff (99.6 %id) | |||
TI_57149432 | .b | 291 to 1020 | 63 to 793 | 731/793 (92 %) | 7 diff (99.2 %id) | ||||
TI_57152836 | .b | 310 to 1045 | 61 to 795 | 735/795 (92 %) | 8 diff (99.0 %id) | ||||
TI_59387216 | .b | 1137 to 1845 | 60 to 774 | 715/779 (91 %) | 17 diff (97.9 %id) | ||||
BP277563 | Kidney | .b | 279 to 860 | 1 to 583 | 583/583 (100 %) | 1 diff (99.9 %id) | |||
DA623975 | Kidney | .b | 280 to 826 | 2 to 548 | capped | 547/547 (100 %) | 2 diff (99.7 %id) | ||
DA626558 | Kidney | .b | 280 to 846 | 2 to 570 | capped | 569/569 (100 %) | 4 diff (99.3 %id) | ||
CB112456 | Liver | .b | 278 to 737 | 1 to 460 | 460/460 (100 %) | 2 diff (99.6 %id) | |||
BP292648 | lung | .b | 569 to 1150 | 1 to 582 | 582/582 (100 %) | 2 diff (99.7 %id) | |||
NM_005558.3 | .b | 62 to 2898 | 1 to 2837 | exact | RefSeq, AAA | 2837/2837 (100 %) | 0 diff (100 %id) | ||
DA761094 | tongue | .b | 110 to 626 | 2 to 518 | capped | 517/517 (100 %) | 1 diff (99.9 %id) | ||
DA763211 | tongue | .b | 280 to 831 | 2 to 553 | capped | 552/552 (100 %) | 0 diff (100 %id) | ||
DA764161 | tongue | .b | 280 to 851 | 2 to 573 | capped | 572/572 (100 %) | 1 diff (99.9 %id) | ||
DA765663 | tongue | .b | 295 to 870 | 2 to 578 | capped | 577/577 (100 %) | 1 diff (99.9 %id) | ||
DA868206 | Prostate | .b | 107 to 582 | 2 to 478 | capped | 477/477 (100 %) | 1 diff (99.8 %id) | ||
BP330051 | rectum | .g-u | 66 to 653 | 1 to 587 | 587/587 (100 %) | 4 diff (99.4 %id) | |||
CR979398 | T-Lymphocytes | .b | 1644 to 2431 | 1 to 789 | 789/789 (100 %) | 1 diff (99.9 %id) | |||
BM785611 | Ascites, stomach | .b | 419 to 1048 | 1 to 627 | 627/627 (100 %) | 3 diff (99.6 %id) | |||
BM797397 | stomach | .b | 2185 to 2520 | 1 to 336 | 336/336 (100 %) | 3 diff (99.2 %id) | |||
BM794531 | stomach | .b | 279 to 493 | 1 to 215 | 215/215 (100 %) | 0 diff (100 %id) | |||
BM854159 | stomach | .b | 2357 to 2519 | 1 to 163 | AAA | 163/163 (100 %) | 0 diff (100 %id) | ||
BM854604 | stomach | .b | 278 to 756 | 1 to 479 | 479/479 (100 %) | 8 diff (98.4 %id) | |||
BM855406 | stomach | .b | 754 to 1151 | 1 to 395 | 395/395 (100 %) | 2 diff (99.5 %id) | |||
BM817783 | stomach | .b | 1514 to 2251 | 1 to 737 | 737/737 (100 %) | 1 diff (99.9 %id) | |||
BM829928 | stomach | .b | 2357 to 2519 | 1 to 163 | AAA | 163/163 (100 %) | 0 diff (100 %id) | ||
BM829951 | stomach | .b | 2357 to 2519 | 1 to 162 | AAA | 162/162 (100 %) | 1 diff (99.4 %id) | ||
BM792782 | Ascites, stomach | .b | 1801 to 2342 | 1 to 542 | 542/542 (100 %) | 0 diff (100 %id) | |||
BM797503 | Ascites, stomach | .b | 1450 to 1626 | 1 to 177 | 177/177 (100 %) | 0 diff (100 %id) | |||
BM823414 | Ascites, stomach | .b | 638 to 1173 | 1 to 536 | 536/536 (100 %) | 1 diff (99.9 %id) | |||
BM826189 | Ascites, stomach | .g-u | 152 to 446 | 1 to 295 | 295/295 (100 %) | 1 diff (99.7 %id) | |||
BM852753 | Ascites, stomach | .d | 13 to 461 | 1 to 448 | 448/448 (100 %) | 2 diff (99.6 %id) | |||
BM852860 | Ascites, stomach | .b | 1565 to 2042 | 1 to 478 | 478/478 (100 %) | 0 diff (100 %id) | |||
BP334070 | salivary gland | .b | 880 to 1379 | 1 to 500 | 500/581 (86 %) | 17 diff (97.1 %id) | |||
DA923826 | small intestine | .b | 280 to 766 | 2 to 488 | capped | 487/487 (100 %) | 1 diff (99.8 %id) | ||
DN995408 | breast cancer, Mammary gland (cancer tissue) | .b | 69 to 693 | 9 to 633 | 625/633 (98 %) | 7 diff (98.9 %id) | |||
DB009331 | colon, tumor tissue | .b | 246 to 808 | 2 to 564 | capped | 563/563 (100 %) | 2 diff (99.7 %id) | ||
DB010778 | colon, tumor tissue | .f | 1 to 549 | 2 to 550 | exact | tiling clone, capped | 549/549 (100 %) | 0 diff (100 %id) | |
DB012975 | esophageal, tumor tissue | .b | 280 to 778 | 2 to 500 | capped | 499/499 (100 %) | 1 diff (99.8 %id) | ||
DB015239 | esophageal, tumor tissue | .b | 250 to 766 | 2 to 518 | capped | 517/517 (100 %) | 1 diff (99.9 %id) | ||
TI_154179984 | .b | 863 to 1691 | 77 to 899 | 823/947 (86 %) | 26 diff (97.3 %id) | ||||
TI_227713565 | .b | 1685 to 2515 | 879 to 61 | AAA | 819/1003 (81 %) | 26 diff (97.5 %id) | |||
DB191030 | lung, tumor tissue | .b | 241 to 821 | 2 to 581 | capped | 580/580 (100 %) | 4 diff (99.4 %id) | ||
DB197688 | trachea | .b | 280 to 870 | 2 to 592 | capped | 591/591 (100 %) | 0 diff (100 %id) | ||
DB198471 | trachea | .b | 251 to 769 | 2 to 521 | capped | 520/520 (100 %) | 1 diff (99.9 %id) | ||
DB202110 | trachea | .b | 295 to 846 | 2 to 553 | capped | 552/552 (100 %) | 0 diff (100 %id) | ||
DB209764 | trachea | .b | 280 to 829 | 2 to 551 | capped | 550/550 (100 %) | 1 diff (99.9 %id) | ||
DB229729 | trachea | .c | 1 to 588 | 2 to 589 | capped | 588/588 (100 %) | 1 diff (99.9 %id) | ||
DB244674 | uterus, tumor tissue | .b | 280 to 847 | 2 to 569 | capped | 568/568 (100 %) | 1 diff (99.9 %id) | ||
DB245709 | uterus, tumor tissue | .b | 280 to 826 | 2 to 548 | capped | 547/547 (100 %) | 0 diff (100 %id) | ||
U42408 | skin | .b | 80 to 2519 | 4 to 2442 | A155P | tiling clone, | 2439/2442 (99 %) | 11 diff (99.6 %id) | |
BQ022579 | placenta | .b | 2278 to 2519 | 259 to 18 | AAA | 242/242 (100 %) | 0 diff (100 %id) | ||
BU689729 | Human Lung Epithelial cells, lung | .b | 1772 to 2519 | 762 to 19 | AAA | 744/744 (100 %) | 10 diff (98.7 %id) | ||
CD364532 | Alveolar Macrophage, lung | .g-u | 91 to 714 | 639 to 16 | AAA | 624/624 (100 %) | 0 diff (100 %id) | ||
BQ355456 | head_neck | .b | 1465 to 2343 | 10 to 899 | Suspected internal deletion, this clone was ignored | 890/1158 (76 %) | 42 diff (96.4 %id) | ||
AI354896 | lung | .b | 1465 to 2343 | 10 to 899 | Suspected internal deletion, this clone was ignored | 890/1158 (76 %) | 42 diff (96.4 %id) | ||
AI620321 | Prostate | .g-u | 170 to 718 | 1 to 549 | Suspected internal deletion, this clone was ignored | 549/549 (100 %) | 0 diff (100 %id) | ||
BE672984 | Prostate | .g-u | 170 to 718 | 1 to 549 | Suspected internal deletion, this clone was ignored | 549/549 (100 %) | 0 diff (100 %id) | ||
BM552193 | astrocytoma grade IV, cell line, brain | .b | 310 to 1215 | 1 to 910 | 910/1044 (87 %) | 22 diff (97.9 %id) | |||
BM552193 | astrocytoma grade IV, cell line, brain | .b | 310 to 1215 | 1 to 910 | 910/1044 (87 %) | 22 diff (97.9 %id) | |||
BM562719 | astrocytoma grade IV, cell line, brain | .b | 310 to 1275 | 1 to 975 | 975/1030 (94 %) | 28 diff (97.3 %id) | |||
BM562719 | astrocytoma grade IV, cell line, brain | .b | 310 to 1275 | 1 to 975 | 975/1030 (94 %) | 28 diff (97.3 %id) | |||
BM128289 | Islets of Langerhans, Pancreas | .b | 309 to 663 | 1 to 355 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 355/433 (81 %) | 5 diff (98.9 %id) | |
BM128289 | Islets of Langerhans, Pancreas | .b | 309 to 663 | 1 to 355 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 355/433 (81 %) | 5 diff (98.9 %id) | |
BM989899 | lung, Lung Focal Fibrosis | .g-u | 148 to 625 | 9 to 486 | Submitted on the opposite strand | 478/486 (98 %) | 6 diff (98.8 %id) | ||
BM989899 | lung, Lung Focal Fibrosis | .g-u | 148 to 625 | 9 to 486 | Submitted on the opposite strand | 478/486 (98 %) | 6 diff (98.8 %id) | ||
CB215986 | normal endometrium, late proliferativephase, cycle day 13, uterus | .b | 2316 to 2525 | 1 to 210 | AAA | 210/210 (100 %) | 0 diff (100 %id) | ||
CB215986 | normal endometrium, late proliferativephase, cycle day 13, uterus | .b | 2316 to 2525 | 1 to 210 | AAA | 210/210 (100 %) | 0 diff (100 %id) | ||
BU191490 | ductal carcinoma, cell line, Pancreas | .b | 3 to 600 | 1 to 600 | 600/1111 (54 %) | 25 diff (97.8 %id) | |||
BU191490 | ductal carcinoma, cell line, Pancreas | .b | 3 to 600 | 1 to 600 | 600/1111 (54 %) | 25 diff (97.8 %id) | |||
BQ685301 | ductal carcinoma, cell line, Pancreas | .b | 304 to 1167 | 1 to 870 | 870/871 (99 %) | 16 diff (98.2 %id) | |||
BQ685301 | ductal carcinoma, cell line, Pancreas | .b | 304 to 1167 | 1 to 870 | 870/871 (99 %) | 16 diff (98.2 %id) | |||
BQ888175 | ductal carcinoma, cell line, Pancreas | .b | 1384 to 2069 | 1 to 695 | 695/984 (70 %) | 23 diff (97.7 %id) | |||
BQ888175 | ductal carcinoma, cell line, Pancreas | .b | 1384 to 2069 | 1 to 695 | 695/984 (70 %) | 23 diff (97.7 %id) | |||
BU859859 | adenocarcinoma, cell line, breast | .b | 1489 to 2373 | 1 to 888 | 888/888 (100 %) | 9 diff (99.0 %id) | |||
BU859859 | adenocarcinoma, cell line, breast | .b | 1489 to 2373 | 1 to 888 | 888/888 (100 %) | 9 diff (99.0 %id) | |||
CF147361 | CNCAP(3)T-225 cell line, Prostate | .b | 864 to 1272 | 9 to 417 | 409/417 (98 %) | 2 diff (99.6 %id) | |||
CF147361 | CNCAP(3)T-225 cell line, Prostate | .b | 864 to 1272 | 9 to 417 | 409/417 (98 %) | 2 diff (99.6 %id) | |||
TI_57149432 | .b | 291 to 1020 | 63 to 793 | 731/793 (92 %) | 7 diff (99.2 %id) | ||||
TI_57152836 | .b | 310 to 1045 | 61 to 795 | 735/795 (92 %) | 8 diff (99.0 %id) | ||||
TI_59387216 | .b | 1137 to 1845 | 60 to 774 | 715/779 (91 %) | 17 diff (97.9 %id) | ||||
BP277563 | Kidney | .b | 279 to 860 | 1 to 583 | 583/583 (100 %) | 1 diff (99.9 %id) | |||
DA623975 | Kidney | .b | 280 to 826 | 2 to 548 | capped | 547/547 (100 %) | 2 diff (99.7 %id) | ||
DA626558 | Kidney | .b | 280 to 846 | 2 to 570 | capped | 569/569 (100 %) | 4 diff (99.3 %id) | ||
CB112456 | Liver | .b | 278 to 737 | 1 to 460 | 460/460 (100 %) | 2 diff (99.6 %id) | |||
BP292648 | lung | .b | 569 to 1150 | 1 to 582 | 582/582 (100 %) | 2 diff (99.7 %id) | |||
NM_005558.3 | .b | 62 to 2898 | 1 to 2837 | exact | RefSeq, AAA | 2837/2837 (100 %) | 0 diff (100 %id) | ||
DA761094 | tongue | .b | 110 to 626 | 2 to 518 | capped | 517/517 (100 %) | 1 diff (99.9 %id) | ||
DA763211 | tongue | .b | 280 to 831 | 2 to 553 | capped | 552/552 (100 %) | 0 diff (100 %id) | ||
DA764161 | tongue | .b | 280 to 851 | 2 to 573 | capped | 572/572 (100 %) | 1 diff (99.9 %id) | ||
DA765663 | tongue | .b | 295 to 870 | 2 to 578 | capped | 577/577 (100 %) | 1 diff (99.9 %id) | ||
DA868206 | Prostate | .b | 107 to 582 | 2 to 478 | capped | 477/477 (100 %) | 1 diff (99.8 %id) | ||
BP330051 | rectum | .g-u | 66 to 653 | 1 to 587 | 587/587 (100 %) | 4 diff (99.4 %id) | |||
CR979398 | T-Lymphocytes | .b | 1644 to 2431 | 1 to 789 | 789/789 (100 %) | 1 diff (99.9 %id) | |||
BM785611 | Ascites, stomach | .b | 419 to 1048 | 1 to 627 | 627/627 (100 %) | 3 diff (99.6 %id) | |||
BM785611 | Ascites, stomach | .b | 419 to 1048 | 1 to 627 | 627/627 (100 %) | 3 diff (99.6 %id) | |||
BM797397 | stomach | .b | 2185 to 2520 | 1 to 336 | 336/336 (100 %) | 3 diff (99.2 %id) | |||
BM794531 | stomach | .b | 279 to 493 | 1 to 215 | 215/215 (100 %) | 0 diff (100 %id) | |||
BM854159 | stomach | .b | 2357 to 2519 | 1 to 163 | AAA | 163/163 (100 %) | 0 diff (100 %id) | ||
BM854604 | stomach | .b | 278 to 756 | 1 to 479 | 479/479 (100 %) | 8 diff (98.4 %id) | |||
BM855406 | stomach | .b | 754 to 1151 | 1 to 395 | 395/395 (100 %) | 2 diff (99.5 %id) | |||
BM817783 | stomach | .b | 1514 to 2251 | 1 to 737 | 737/737 (100 %) | 1 diff (99.9 %id) | |||
BM829928 | stomach | .b | 2357 to 2519 | 1 to 163 | AAA | 163/163 (100 %) | 0 diff (100 %id) | ||
BM829951 | stomach | .b | 2357 to 2519 | 1 to 162 | AAA | 162/162 (100 %) | 1 diff (99.4 %id) | ||
BM792782 | Ascites, stomach | .b | 1801 to 2342 | 1 to 542 | 542/542 (100 %) | 0 diff (100 %id) | |||
BM792782 | Ascites, stomach | .b | 1801 to 2342 | 1 to 542 | 542/542 (100 %) | 0 diff (100 %id) | |||
BM797503 | Ascites, stomach | .b | 1450 to 1626 | 1 to 177 | 177/177 (100 %) | 0 diff (100 %id) | |||
BM797503 | Ascites, stomach | .b | 1450 to 1626 | 1 to 177 | 177/177 (100 %) | 0 diff (100 %id) | |||
BM823414 | Ascites, stomach | .b | 638 to 1173 | 1 to 536 | 536/536 (100 %) | 1 diff (99.9 %id) | |||
BM823414 | Ascites, stomach | .b | 638 to 1173 | 1 to 536 | 536/536 (100 %) | 1 diff (99.9 %id) | |||
BM826189 | Ascites, stomach | .g-u | 152 to 446 | 1 to 295 | 295/295 (100 %) | 1 diff (99.7 %id) | |||
BM826189 | Ascites, stomach | .g-u | 152 to 446 | 1 to 295 | 295/295 (100 %) | 1 diff (99.7 %id) | |||
BM852753 | Ascites, stomach | .d | 13 to 461 | 1 to 448 | 448/448 (100 %) | 2 diff (99.6 %id) | |||
BM852753 | Ascites, stomach | .d | 13 to 461 | 1 to 448 | 448/448 (100 %) | 2 diff (99.6 %id) | |||
BM852860 | Ascites, stomach | .b | 1565 to 2042 | 1 to 478 | 478/478 (100 %) | 0 diff (100 %id) | |||
BM852860 | Ascites, stomach | .b | 1565 to 2042 | 1 to 478 | 478/478 (100 %) | 0 diff (100 %id) | |||
BP334070 | salivary gland | .b | 880 to 1379 | 1 to 500 | 500/581 (86 %) | 17 diff (97.1 %id) | |||
DA923826 | small intestine | .b | 280 to 766 | 2 to 488 | capped | 487/487 (100 %) | 1 diff (99.8 %id) | ||
DN995408 | breast cancer, Mammary gland (cancer tissue) | .b | 69 to 693 | 9 to 633 | 625/633 (98 %) | 7 diff (98.9 %id) | |||
DN995408 | breast cancer, Mammary gland (cancer tissue) | .b | 69 to 693 | 9 to 633 | 625/633 (98 %) | 7 diff (98.9 %id) | |||
DB009331 | colon, tumor tissue | .b | 246 to 808 | 2 to 564 | capped | 563/563 (100 %) | 2 diff (99.7 %id) | ||
DB010778 | colon, tumor tissue | .f | 1 to 549 | 2 to 550 | exact | tiling clone, capped | 549/549 (100 %) | 0 diff (100 %id) | |
DB012975 | esophageal, tumor tissue | .b | 280 to 778 | 2 to 500 | capped | 499/499 (100 %) | 1 diff (99.8 %id) | ||
DB015239 | esophageal, tumor tissue | .b | 250 to 766 | 2 to 518 | capped | 517/517 (100 %) | 1 diff (99.9 %id) | ||
TI_154179984 | .b | 863 to 1691 | 77 to 899 | 823/947 (86 %) | 26 diff (97.3 %id) | ||||
TI_227713565 | .b | 1685 to 2515 | 879 to 61 | AAA | 819/1003 (81 %) | 26 diff (97.5 %id) | |||
DB191030 | lung, tumor tissue | .b | 241 to 821 | 2 to 581 | capped | 580/580 (100 %) | 4 diff (99.4 %id) | ||
DB197688 | trachea | .b | 280 to 870 | 2 to 592 | capped | 591/591 (100 %) | 0 diff (100 %id) | ||
DB198471 | trachea | .b | 251 to 769 | 2 to 521 | capped | 520/520 (100 %) | 1 diff (99.9 %id) | ||
DB202110 | trachea | .b | 295 to 846 | 2 to 553 | capped | 552/552 (100 %) | 0 diff (100 %id) | ||
DB209764 | trachea | .b | 280 to 829 | 2 to 551 | capped | 550/550 (100 %) | 1 diff (99.9 %id) | ||
DB229729 | trachea | .c | 1 to 588 | 2 to 589 | capped | 588/588 (100 %) | 1 diff (99.9 %id) | ||
DB244674 | uterus, tumor tissue | .b | 280 to 847 | 2 to 569 | capped | 568/568 (100 %) | 1 diff (99.9 %id) | ||
DB245709 | uterus, tumor tissue | .b | 280 to 826 | 2 to 548 | capped | 547/547 (100 %) | 0 diff (100 %id) | ||
U42408 | skin | .b | 80 to 2519 | 4 to 2442 | A155P | tiling clone, | 2439/2442 (99 %) | 11 diff (99.6 %id) | |
BQ022579 | placenta | .b | 2278 to 2519 | 259 to 18 | AAA | 242/242 (100 %) | 0 diff (100 %id) | ||
BU689729 | Human Lung Epithelial cells, lung | .b | 1772 to 2519 | 762 to 19 | AAA | 744/744 (100 %) | 10 diff (98.7 %id) | ||
BU689729 | Human Lung Epithelial cells, lung | .b | 1772 to 2519 | 762 to 19 | AAA | 744/744 (100 %) | 10 diff (98.7 %id) | ||
CD364532 | Alveolar Macrophage, lung | .g-u | 91 to 714 | 639 to 16 | AAA | 624/624 (100 %) | 0 diff (100 %id) | ||
CD364532 | Alveolar Macrophage, lung | .g-u | 91 to 714 | 639 to 16 | AAA | 624/624 (100 %) | 0 diff (100 %id) |